Press Releases

Lilly and Precision BioSciences Announce Genome Editing Research Collaboration and License Agreement

November 20, 2020

Tags |  Corporate

Research collaboration using ARCUS genome editing technology will initially include three gene targets, with right to select three additional gene targets; lead program focused on Duchenne Muscular Dystrophy   Precision will receive $100 million cash upfront and an equity investment by Lilly of $35

Aarti Shah to Retire as Lilly Chief Information and Digital Officer

November 5, 2020

Tags |  Corporate

Shah will retire in the first half of 2021, successor to be named at a later date INDIANAPOLIS , Nov. 5, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) announced today that Aarti Shah , Ph.D., senior vice president and chief information and digital officer, will retire in the first half of

Lilly Announces Agreement to Acquire Disarm Therapeutics

October 15, 2020

Tags |  Corporate

Acquisition expands Lilly's R&D efforts in pain and neurodegeneration with the addition of Disarm's promising preclinical SARM1 programs for axonal degeneration INDIANAPOLIS and CAMBRIDGE, Mass. , Oct. 15, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) today announced a definitive

Lilly Announces Arrangement for Supply of Potential COVID-19 Antibody Therapy for Low- and Middle-Income Countries

October 8, 2020

Tags |  Corporate

INDIANAPOLIS , Oct. 8, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and the Bill & Melinda Gates Foundation , as part of the COVID-19 Therapeutics Accelerator, have entered into an agreement to facilitate access to future Lilly therapeutic antibodies under development for the prevention

Lilly and Amgen Announce Manufacturing Collaboration for COVID-19 Antibody Therapies

September 17, 2020

Tags |  Corporate

Agreement will significantly increase global supply capacity for Lilly's potential COVID-19 treatments INDIANAPOLIS and THOUSAND OAKS, Calif. , Sept. 17, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and Amgen (NASDAQ:AMGN) today announced a global antibody manufacturing collaboration to

Lilly Launches Digital Health Open Innovation Challenge to Help Transform Atopic Dermatitis Care

September 15, 2020

Tags |  Corporate

INDIANAPOLIS , Sept. 15, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) has launched an open innovation challenge for individuals and teams across the United States to submit inspiring digital health solutions that can help make life better for people living with atopic dermatitis.

Lilly Announces Leadership Changes

September 9, 2020

Tags |  Corporate

Patrik Jonsson named Senior Vice President, President of Lilly USA and Chief Customer Officer   Ilya Yuffa promoted to Senior Vice President and President of Lilly Bio-Medicines INDIANAPOLIS , Sept. 9, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) announced today that Patrik Jonsson ,

Lilly and Innovent Announce Global Expansion of TYVYT Licensing Agreement

August 18, 2020

Tags |  Corporate

INDIANAPOLIS and SUZHOU, China , Aug. 18, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) and Innovent Biologics, Inc. (HKEX: 01801) today announced a global expansion of their strategic alliance for TYVYT ® (sintilimab injection), an anti-PD-1 monoclonal antibody immuno-oncology medicine

Central Indiana Racial Equity Fund Launches with more than $2.2 Million in Initial Commitments

June 25, 2020

Tags |  Corporate

The fund, established by the Eli Lilly and Company Foundation, Lumina Foundation and Central Indiana Community Foundation, will focus on solutions that address racial inequities in the criminal justice system INDIANAPOLIS , June 25, 2020 /PRNewswire/ -- A coalition of local stakeholders has

Eli Lilly and Company Foundation Pledges $25 Million to Combat Racial Injustice

June 13, 2020

Tags |  Corporate

Eli Lilly and Company commits 25,000 employee volunteer hours of service to help speed progress INDIANAPOLIS , June 13, 2020 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) and the Lilly Foundation announced today a pledge of $25 million and 25,000 volunteer hours over five years to decrease the